The EULAR COVAX-19 Registry will be closed on 31 October 2022. We encourage all rheumatologists, physicians, epidemiologists, healthcare professionals, national societies, and patients, who have any cases to report, to submit your data as soon as possible until the final closure of the Registry.
About the EULAR COVAX Registry
The COVID-19 pandemic has severely influenced all aspects of life in 2020. This pandemic also affected people with RMDs, and impacted the care given to them. With the development of vaccines, the future is becoming brighter. However, the possibility of vaccination also raises questions, especially for patients with inflammatory RMDs and patients that are treated with drugs that may influence their immune system.
EULAR has set up a very simple survey to be filled in online after consultation with an RMD patient any time after her/his first or second injection of COVID-19 vaccination. This data will be an important contribution to the arguments brought forward to encourage patients to be vaccinated. For patients without adverse events the survey should take 1-2 minutes to complete. For patients with adverse events the survey should take less than 5 minutes to complete. Please support this important initiative by reporting cases.
Please help EULAR address these questions by responding to the survey of the "Button Above"
EULAR COVAX survey
see survey example
- Please report all COVID-19 vaccinated RMD patients, with inflammatory or non-inflammatory conditions.
- Please report all COVID-19 vaccinated RMD patients, with or without vaccine-related adverse events.
- Please submit reports at any time after the first or second dose of the vaccine.
- Please do not report adverse events that are definitely not related with the vaccine administration.
Reporting the maximum number of cases, including cases without adverse events, is extremely important as this will allow us to understand better how common a certain adverse event is.
29 April 2022
EULAR COVID-19 Registry
The EULAR - COVID-19 Registry is a European paediatric and adult registry to monitor and report on outcomes of COVID-19 occurring in patients with RMDs.
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
If you have any questions about these registries please send an e-mail to firstname.lastname@example.org .
Please note that this email address is for technological clarifications about the Registry and NOT for patient data and queries.